therapeutics in Germany
therapeutics [θerəpjuːtiks] Therapeutik
Sentence patterns related to "therapeutics"
1. About Akebia Therapeutics Akebia Therapeutics, Inc
2. Allopathy+homeopathic Therapeutics
3. 8 Allogene Therapeutics reviews
4. ©2021 Akebia Therapeutics, Inc
5. In Q4, Akebia Therapeutics brought
6. Ascidian THERAPEUTICS, INC (Delaware (US))
7. Acrs Complete Aclaris Therapeutics Inc
8. Cancer startup Allogene Therapeutics Inc
9. Atalanta Therapeutics General Information Description
10. Cedilla Therapeutics General Information Description
11. View the latest Allogene Therapeutics Inc
12. Cere Complete Cerevel Therapeutics Holdings Inc
13. Allogene Therapeutics 25,382 followers on LinkedIn
14. 22, 2021-- Arcturus Therapeutics Holdings Inc
15. About Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering …
16. 08, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc
17. Allogene Therapeutics is funded by 14 investors.
18. Bellerophon Therapeutics (BLPH) Reports Q3 Loss, Lags Revenue Estimates Bellerophon Therapeutics (BLPH) delivered earnings and revenue surprises of -2.44% and …
19. Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases.
20. 23, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc
21. Crispr Therapeutics to Participate in Upcoming Investor Conferences
22. Biosimilar adjective Referring to a Biosimilar therapeutics agent
23. A high-level overview of Beam Therapeutics Inc
24. Allogene Therapeutics is now valued at $5 billion
25. Allogene Therapeutics is registered under the ticker NASDAQ:ALLO
26. AKBA Akebia Therapeutics — Stock Price and Discussion Stocktwits
27. A high-level overview of Aprea Therapeutics, Inc
28. Antisense oligonucleotide-based therapeutics involves downregulation of gene expression
29. View Aclaris Therapeutics, Inc. Acrs investment & stock information
30. Allogene Therapeutics is a clinical stage immuno-oncology company
31. Get the lAtest stock price for Antibe Therapeutics Inc
32. Akebia Therapeutics NASDAQ Updated Jun 25, 2021 11:50 PM
33. Biom Therapeutics Bio-pharmaceutical company developing therapeutics for rare neurological childhood diseases Learn More A B O U T U S Biom Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for brain disorders
34. Neuralstem (Cur) Stock Rises Today as Brainstorm Cell Therapeutics Soars
35. A high-level overview of Alterity Therapeutics Limited (Athe) stock
36. Beam Therapeutics has received 64.29% “underperform” votes from our community
37. Crisper Therapeutics shares decline on wider-than-expected loss Jul
38. Aprea Therapeutics PRIVATE Updated Mar 25, 2021 8:45 AM
39. Antisense & RNAi Therapeutics Market Regional And Country Analysis 5.1
40. Bellerophon Therapeutics NASDAQ Updated Mar 24, 2021 11:54 PM
41. You are leaving Akebia.com, a website of Akebia Therapeutics, Inc
42. Antisense & RNAi Therapeutics Market Regional And Country Analysis 5.1
43. Aileron Therapeutics NASDAQ Updated Mar 19, 2021 11:57 PM
44. Get the latest Aclaris Therapeutics, Inc. Acrs detailed stock quotes, …
45. Crispr Therapeutics has established a portfolio of therapeutic programs across a
46. During Q1, Akebia Therapeutics (NASDAQ:AKBA) brought in sales totaling $52.30 million
47. During Q1, Akebia Therapeutics (NASDAQ:AKBA) brought in sales totaling $52.30 million
48. The Biologic therapeutics market analysis includes the product segment and geographic landscape
49. What does Aceology mean? The science of remedies, or of therapeutics; iamatology
50. Aprea Therapeutics started at neutral with $23 stock price target at J.P